MRNA vs. LAC
MRNA (Moderna, Inc.) and LAC (Lithium Americas Corp.) are both stocks. MRNA operates in Biotechnology (Healthcare), while LAC operates in Other Industrial Metals & Mining (Basic Materials). Over the past year, MRNA returned 87.14% vs 71.70% for LAC. At a 0.29 correlation, their price movements are largely independent.
Performance
MRNA vs. LAC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRNA achieves a 69.24% return, which is significantly higher than LAC's 4.36% return.
MRNA
- 1D
- 0.54%
- 1M
- 1.77%
- YTD
- 69.24%
- 6M
- 69.42%
- 1Y
- 87.14%
- 3Y*
- -26.94%
- 5Y*
- -25.59%
- 10Y*
- —
LAC
- 1D
- 3.17%
- 1M
- -9.18%
- YTD
- 4.36%
- 6M
- -11.13%
- 1Y
- 71.70%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MRNA vs. LAC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
MRNA Moderna, Inc. | 69.24% | -29.08% | -58.19% | -3.72% |
LAC Lithium Americas Corp. | 4.36% | 46.80% | -53.59% | -27.19% |
Correlation
The correlation between MRNA and LAC is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Oct 2, 2023 | 0.29 |
Fundamentals
MRNA:
$19.71B
LAC:
$1.61B
MRNA:
-$8.16
LAC:
-$0.28
MRNA:
2.66
LAC:
1.19
MRNA:
$2.23B
LAC:
$0.00
MRNA:
-$309.00M
LAC:
-$580.22K
MRNA:
-$3.02B
LAC:
-$52.10M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRNA vs. LAC — Risk / Return Rank
MRNA
LAC
MRNA vs. LAC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Moderna, Inc. (MRNA) and Lithium Americas Corp. (LAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRNA | LAC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.73 | ||
| Sortino ratioReturn per unit of downside risk | -0.08 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.25 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 2.34 | 1.16 | +1.17 |
| Martin ratioReturn relative to average drawdown | 4.59 | 1.77 | +2.82 |
Loading charts...
Drawdowns
MRNA vs. LAC - Drawdown Comparison
The maximum MRNA drawdown since its inception was -95.38%, which is greater than LAC's maximum drawdown of -81.83%. Use the drawdown chart below to compare losses from any high point for MRNA and LAC.
Loading charts...
Drawdown Indicators
| MRNA | LAC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.38% | -81.83% | -13.55% |
Max Drawdown (1Y)Largest decline over 1 year | -35.51% | -63.08% | +27.57% |
Max Drawdown (3Y)Largest decline over 3 years | -86.58% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -95.38% | — | — |
Current DrawdownCurrent decline from peak | -89.70% | -61.18% | -28.52% |
Average DrawdownAverage peak-to-trough decline | -57.06% | -63.13% | +6.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.06% | 41.47% | -23.41% |
Volatility
MRNA vs. LAC - Volatility Comparison
The current volatility for Moderna, Inc. (MRNA) is 17.56%, while Lithium Americas Corp. (LAC) has a volatility of 22.78%. This indicates that MRNA experiences smaller price fluctuations and is considered to be less risky than LAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRNA | LAC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.56% | 22.78% | -5.22% |
Volatility (6M)Calculated over the trailing 6-month period | 48.82% | 53.55% | -4.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 64.75% | 132.17% | -67.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.49% | 101.55% | -35.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.15% | 101.55% | -29.40% |
Dividends
MRNA vs. LAC - Dividend Comparison
Neither MRNA nor LAC has paid dividends to shareholders.
Financials
MRNA vs. LAC - Financials Comparison
This section allows you to compare key financial metrics between Moderna, Inc. and Lithium Americas Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MRNA and LAC have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LAC has higher volatility (22.78%) compared to MRNA (17.56%). In terms of maximum drawdown, MRNA dropped -95.38% vs LAC's -81.83%.
MRNA currently has the higher Sharpe Ratio (1.28 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRNA and LAC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer